Published in AIDS Weekly, October 16th, 2000
"We hypothesized that an HIV-1 immunogen (whole-killed gp120-depleted HIV-1 in IFA, Remune), which contains multiple viral antigens, would stimulate immune responses to autologous virus," stated R.B. Moss and colleagues from The Immune Response Corporation, and the U.S. Naval Hospital, California. "In this study, we examined five chronically HIV infected individuals for HIV specific immune responses including autologous virus after treatment with the HIV-1 immunogen."
Moss et al. presented data from their study at the 40th Interscience Conference...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.